Skip to main content

Table 5 Incremental cost-effectiveness ratios of pregabalin vs. gabapentin in the treatment of painful DPN and PHN

From: Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting

  Pregabalin vs Gabapentin
Cost per additional (€) Mean (95% CI)
Day with no or mild pain
     Mean estimate 13
     95% confidence interval (8, 18)
QALY gained
     Mean estimate 19,320
     95% confidence interval (11,743 - 26,755)